Product Images Sildenafil

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Sildenafil NDC 76420-061 by Asclemed Usa, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

20mg-30s - sildenafil 20mg 30s

20mg-30s - sildenafil 20mg 30s

Description: Sildenafil Tablets, USP 20mg is a medication manufactured by Macleods Pharma USA Inc. It comes in a package of 30 tablets with each tablet containing 20mg of the active ingredient sildenafil. The tablets are round, white, film-coated, and have "C 69" imprinted on them. The NDC code for this medication is 76420-061-30 and the source NDC is 33342.121-10. This medication is commonly used to treat erectile dysfunction (ED) in men.*

20mg-90's - sildenafil 20mg 90s

20mg-90's - sildenafil 20mg 90s

Description: Rolabood By Enovachem is a medication presented in tablets of 20mg and with NDC code 76420-061-90. The lot number is 000000, and the expiration date is 001000000 10000000. It should be stored at 25-27°C (77°F) in a controlled room temperature and kept out of the reach of children. The drug stats indicate it is available only through prescription (RX).*

figure-10 - sildenafil fig 10

figure-10 - sildenafil fig 10

Not available. The text seems to be a random set of letters, numbers and symbols that do not form a coherent description of anything in particular. It is likely that the was not able to accurately detect and transcribe the original text.*

figure-11 - sildenafil fig 11

figure-11 - sildenafil fig 11

fig-12 - sildenafil fig 12

fig-12 - sildenafil fig 12

fig-6 - sildenafil fig 6

fig-6 - sildenafil fig 6

fig-8 - sildenafil fig 8

fig-8 - sildenafil fig 8

The text appears to be a chart or table showing the fold change and recommendations for different drugs, along with the dosage adjustment required when interacting with other drugs. The chart also includes some values related to the relative change of certain drugs and a note regarding the effects of Ritonavir on Sidenafil PK.*

figure-9 - sildenafil fig 9

figure-9 - sildenafil fig 9

figure-7 - sildenafil figure 7

figure-7 - sildenafil figure 7

This text appears to be a table or a chart featuring different drugs and their impact on AUC and Cmax. The chart indicates that some drugs do not require a dose adjustment when taken with others, while some require monitoring when co-administered. The chart also shows the relative changes in AUC accumulation ratio from day 10 to day 7 when compared to taking sildenafil alone. The text mentions clinical studies but does not provide any further specific details.*

str - sildenafil str

str - sildenafil str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.